Centogene N.V. (CNTGF)
OTCMKTS · Delayed Price · Currency is USD
0.1017
+0.0017 (1.70%)
Oct 31, 2025, 1:38 PM EDT
Centogene Market Cap
Centogene has a market cap or net worth of $2.98 million as of October 31, 2025. Its market cap has decreased by -74.10% in one year.
Market Cap
2.98M
Enterprise Value
70.67M
Revenue
53.65M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.10
Market Cap Chart
Since November 5, 2019, Centogene's market cap has decreased from 3.22M to 2.98M, a decrease of -7.40%. That is a compound annual growth rate of -1.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2025 | 2.98M | -24.18% |
| Dec 31, 2024 | 3.93M | -88.24% |
| Dec 29, 2023 | 33.44M | 32.77% |
| Dec 30, 2022 | 25.19M | -78.60% |
| Dec 31, 2021 | 117.70M | -50.06% |
| Dec 31, 2020 | 235.67M | 17.83% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 5, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 815.18M |
| Elite Pharmaceuticals | 655.38M |
| Glass House Brands | 569.74M |
| Northwest Biotherapeutics | 366.55M |
| Silence Therapeutics | 345.28M |
| Nika Pharmaceuticals | 312.10M |
| American Oncology Network | 305.06M |
| CytoDyn | 302.34M |